A Phase I Study of Mosunetuzumab for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Shanghai Pudong Hospital
Second Affiliated Hospital of Xi'an Jiaotong University
Jonsson Comprehensive Cancer Center
University of Alabama at Birmingham
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Enzon Pharmaceuticals, Inc.